Hemodynamic rounds series II: Hemodynamic effects of alcohol-induced septal infarction for hypertrophic obstructive cardiomyopathy

Catheterization and Cardiovascular Interventions

Volumn 47, Issue 2, 1999, Pages 221-228

  Kern, Morton J ^a,b   Rajjoub, Hassan ^a   Bach, Richard ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SAINT LOUIS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL;

ADULT; ARTICLE; ATRIOVENTRICULAR CONDUCTION; CASE REPORT; CORONARY ARTERY BLOOD FLOW; DYSPNEA; HEART HEMODYNAMICS; HEART INFARCTION; HEART LEFT VENTRICLE PRESSURE; HEART VENTRICLE SEPTUM; HUMAN; HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY; MALE; SYNCOPE; THORAX PAIN; TREATMENT CONTRAINDICATION; TREATMENT OUTCOME;

AGED; CARDIAC PACING, ARTIFICIAL; CARDIOMYOPATHY, HYPERTROPHIC; CATHETER ABLATION; ETHANOL; HEART SEPTUM; HEMODYNAMIC PROCESSES; HUMANS; INFARCTION; MALE; MIDDLE AGED; TREATMENT OUTCOME; VENTRICULAR FUNCTION;

EID: 0032992541     PISSN: 15221946     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1522-726X(199906)47:2<221::AID-CCD22>3.0.CO;2-6     Document Type: Article

References (23)

1. Braunwald E, Lambrew CT, Rickoff SD, Ross J Jr, Morrow AG. Idiopathic hypertrophic subaortic stenosis. I. A description of the disease based upon an analysis of 64 patients. Circulation 1964; 30(suppl 4):3-119.
2. Rosing DR, Idanpaan-Heikkila U, Maron BJ, Bonow RO, Epstein SE. Use of calcium-blocking drugs in hypertrophic cardiomyopathy. Am J Cardiol 1985;55:185B-195B.
3. Morrow AG, Reitz BA, Epstein SE, Henry WL, Conkle DM, Itscoitz SB, Redwood DR. Operative treatment in hypertrophic subaortic stenosis: techniques and the results of pre- and post-operative assessment in 83 patients. Circulation 1975;52:88-102.
4. Mohr R, Schaff HV, Danielson GK, Puga FJ, Pluth JR, Tajik AJ. The outcome of surgical treatment of hypertrophic obstructive cardiomyopathy: experience over 15 years. J Thorac Cardiovasc Surg 1989;97:666-674.
5. Krajcer Z, Leachman R, Cooley D, Coronado R. Septal myotomy-myomectomy versus mitral valve replacement in hypertrophic cardiomyopathy: ten year follow-up in 185 patients. Circulation 1989;80(suppl 1):I57-I64.
6. Fananapazir L, Canon RO III, Tripodi D, Panza JA. Impact of dual chamber permanent pacing in patients with obstructive hypertrophic cardiomyopathy with symptoms refractory to verapamil and beta-adrenergic blocker therapy. Circulation 1992;85:2149-2161.
7. Jeanrenaud X, Goy J-J, Kappenberger L. Effects of dual-chamber pacing in hypertrophic obstructive cardiomyopathy. Lancet 1992; 339:1318-1323.
8. Sigwart U. Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy. Lancet 1995;346:211-214.
9. Knight C, Kurbaan AS, Seggewiss H, Henein M, Gunning M, Harrington D, Fassbender D, Gleichmann U, Sigwart U. Nonsurgical septal reduction for hypertrophic obstructive cardiomyopathy: outcome in the first series of patients. Circulation 1997;95:2075-2081.
10. Seggewiss H, Gleichmann U, Faber L, Fassbender D, Schmidt HK, Strick S. Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: acute results and 3-month follow-up in 25 patients. J Am Coll Cardiol 1998;31:252-258.
11. Oakley CM. Non-surgical ablation of the ventricular septum for the treatment of hypertrophic cardiomyopathy. Lancet 1995;346: 1624.
12. Braunwald E. Induced septal infarction: a new therapeutic strategy for hypertrophic obstructive cardiomyopathy. Circulation 1997;95: 1981-1982.
13. Fananapazir L, Epstein ND, Panza A, Curiel R, Tripodi D, McAreavey D. Long-term results of dual chamber (DDD) pacing in obstructive hypertrophic cardiomyopathy: evidence for progressive symptomatic and hemodynamic improvement and reduction of left ventricular hypertrophy. Circulation 1994;90:2731-2742.
14. Simon JP, Sadoul N, de Chillou C, et al. Long-term dual chamber pacing improves hemodynamic function in patients with obstructive hypertrophic cardiomyopathy. PACE (Abstract) 1995;18: 1769.
15. Sadoul N, Simon J-P, Bruntz J-F, Isaaz K, de Chillou C, Beurrier D, Dodinot B, Aliot E. Long-term dual chamber pacing reduces left ventricular mass in patients with obstructive hypertrophic cardiomyopathy. J Am Coll Cardiol 1993;21:94A.
16. McAreavey D, Fananapazir L. Altered cardiac hemodynamic and electrical state in normal sinus rhythm following chronic dual chamber pacing for relief of left ventricular outflow obstruction in hypertrophic cardiomyopathy. Am J Cardiol 1992;70:651-656.
17. Fananapazir L, Dilsizian V, Bonow RO. Dual chamber pacing relieves angina and improves myocardial perfusion abnormalities in patients with obstructive hypertrophic cardiomyopathy. Circulation 1992;86:I272.
18. Fananapazir L, McAreavey D. Therapeutic options in patients with obstructive hypertrophic cardiomyopathy and severe drug-refractory symptoms. J Am Coll Cardiol 1998;31:259-264.
19. Kizilbash AM, Heinle SK, Grayburn PA. Spontaneous variability of left ventricular outflow tract gradient in hypertrophic obstructive cardiomyopathy. Circulation 1998;97:461-466.
20. Spirito P, Chiarella F, Carratino L, Berisso MZ, Bellotti P, Vecchio C. Clinical course and prognosis of hypertrophic cardiomyopathy in an out-patient population. N Engl J Med 1989;320:749-755.
21. Maron BJ, Bonow RO, Cannon RO, Leon MB, Epstein SE. Hypertrophic cardiomyopathy: interrelations of clinical manifestations, pathophysiology, and therapy. N Engl J Med 1987;316:780-789, 844-852.
22. McCully RB, Nishimura RA, Tajik AJ, Schaff HV, Danielson GK. Extent of clinical improvement after surgical treatment of hypertrophic obstructive cardiomyopathy. Circulation 1996;94:467-471.
23. Heric B, Lytle BW, Miller DP, Rosenkranz ER, Lever HM, Cosgrove DM. Surgical management of hypertrophic obstructive cardiomyopathy: early and late results. J Thorac Cardiovasc Surg 1995;110:195-208.